Target Healthcare REIT PLC (LON:THRL)
London · Delayed Price · Currency is GBP · Price in GBX 112.40
+0.80 (0.72%)
Aug 28, 2026, 4:36 PM GMT
Target Healthcare REIT Balance Sheet
Financials in millions GBP. Fiscal year is July - June.
Millions GBP. Fiscal year is Jul - Jun.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Property, Plant & Equipment | 809.7 | 840.43 | 831.57 | 800.16 | 857.69 | 631.16 |
Cash & Equivalents | 67.17 | 39.64 | 38.88 | 15.37 | 34.48 | 21.11 |
Accounts Receivable | 0.7 | 1.43 | 1.22 | 1.36 | 1.11 | 1.13 |
Other Receivables | 1.59 | 2.25 | 4.44 | 3.81 | 4.44 | 2.85 |
Investment In Debt and Equity Securities | - | - | 2.82 | 6.91 | 2.28 | 0.25 |
Other Current Assets | - | - | - | 4.3 | - | 7.32 |
Trading Asset Securities | - | 0.57 | - | - | - | - |
Other Long-Term Assets | 97.35 | 101.86 | 88.43 | 76.37 | 63.65 | 54.58 |
Total Assets | 976.51 | 986.19 | 967.37 | 908.26 | 963.66 | 718.39 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Current Portion of Long-Term Debt | - | 91.85 | - | - | - | - |
Long-Term Debt | 201.39 | 148.44 | 240.67 | 227.05 | 231.38 | 127.9 |
Accounts Payable | 3.3 | 2.86 | 2.46 | 2.37 | 2.62 | 2.04 |
Accrued Expenses | 3.86 | 4.2 | 6.11 | 3.83 | 3.66 | 4.07 |
Current Income Taxes Payable | - | - | - | - | 2.8 | - |
Current Unearned Revenue | 11.59 | 10.46 | 10.15 | 8.24 | 8.39 | 5.72 |
Other Current Liabilities | 3.27 | 3.22 | 8.79 | 3.88 | 8.89 | 6.63 |
Other Long-Term Liabilities | 12.82 | 12.7 | 9.89 | 8.09 | 7.15 | 6.84 |
Total Liabilities | 236.22 | 273.73 | 278.08 | 253.45 | 264.89 | 153.21 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Common Stock | 6.2 | 6.2 | 6.2 | 6.2 | 6.2 | 5.12 |
Additional Paid-In Capital | 256.63 | 256.63 | 256.63 | 256.63 | 256.63 | 135.23 |
Retained Earnings | 302.56 | 300.08 | 299.3 | 298.28 | 302.15 | 312.73 |
Comprehensive Income & Other | 174.89 | 149.54 | 127.16 | 93.69 | 133.79 | 112.11 |
Shareholders' Equity | 740.28 | 712.46 | 689.29 | 654.81 | 698.77 | 565.19 |
Total Liabilities & Equity | 976.51 | 986.19 | 967.37 | 908.26 | 963.66 | 718.39 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Total Debt | 201.39 | 240.29 | 240.67 | 227.05 | 231.38 | 127.9 |
Net Cash (Debt) | -134.22 | -200.08 | -201.79 | -211.69 | -196.9 | -106.8 |
Net Cash (Debt) Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.22 | -0.32 | -0.33 | -0.34 | -0.33 | -0.22 |
Filing Date Shares Outstanding | 620.24 | 620.24 | 620.24 | 620.24 | 620.24 | 620.24 |
Total Common Shares Outstanding | 620.24 | 620.24 | 620.24 | 620.24 | 620.24 | 511.54 |
Book Value Per Share | 1.19 | 1.15 | 1.11 | 1.06 | 1.13 | 1.10 |
Tangible Book Value | 740.28 | 712.46 | 689.29 | 654.81 | 698.77 | 565.19 |
Tangible Book Value Per Share | 1.19 | 1.15 | 1.11 | 1.06 | 1.13 | 1.10 |